spacer
spacer

PDBsum entry 1mqb

Go to PDB code: 
protein ligands links
Transferase PDB id
1mqb

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
263 a.a. *
Ligands
ANP ×2
Waters ×66
* Residue conservation analysis
PDB id:
1mqb
Name: Transferase
Title: Crystal structure of ephrin a2 (epha2) receptor protein kinase
Structure: Ephrin type-a receptor 2. Chain: a, b. Fragment: kinase domain. Synonym: epha2 receptor tyrosine kinase, tyrosine-protein kinase receptor eck, epithelial cell kinase. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: epha2. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: hi5.
Resolution:
2.30Å     R-factor:   0.236     R-free:   0.288
Authors: J.Nowakowski,C.N.Cronin,D.E.Mcree,M.W.Knuth,C.Nelson,N.Pavletich, J.Rogers,B.C.Sang,D.N.Scheibe,R.V.Swanson,D.A.Thompson
Key ref:
J.Nowakowski et al. (2002). Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography. Structure, 10, 1659-1667. PubMed id: 12467573 DOI: 10.1016/S0969-2126(02)00907-3
Date:
16-Sep-02     Release date:   16-Sep-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P29317  (EPHA2_HUMAN) -  Ephrin type-A receptor 2 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
976 a.a.
263 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.1  - receptor protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
Bound ligand (Het Group name = ANP)
matches with 81.25% similarity
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/S0969-2126(02)00907-3 Structure 10:1659-1667 (2002)
PubMed id: 12467573  
 
 
Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography.
J.Nowakowski, C.N.Cronin, D.E.McRee, M.W.Knuth, C.G.Nelson, N.P.Pavletich, J.Rogers, B.C.Sang, D.N.Scheibe, R.V.Swanson, D.A.Thompson.
 
  ABSTRACT  
 
Protein kinases are important drug targets in human cancers, inflammation, and metabolic diseases. This report presents the structures of kinase domains for three cancer-associated protein kinases: ephrin receptor A2 (EphA2), focal adhesion kinase (FAK), and Aurora-A. The expression profiles of EphA2, FAK, and Aurora-A in carcinomas suggest that inhibitors of these kinases may have inherent potential as therapeutic agents. The structures were determined from crystals grown in nanovolume droplets, which produced high-resolution diffraction data at 1.7, 1.9, and 2.3 A for FAK, Aurora-A, and EphA2, respectively. The FAK and Aurora-A structures are the first determined within two unique subfamilies of human kinases, and all three structures provide new insights into kinase regulation and the design of selective inhibitors.
 
  Selected figure(s)  
 
Figure 5.
Figure 5. Stereo Diagrams of the ATP Binding Sites(A) Aurora-A ATP binding site. Carbon atoms, gray; oxygen atoms, red; nitrogen atoms, blue; phosphorus atoms, green. Water molecules and Mg2+ ions are represented by red and blue crosses, respectively.(B) FAK ATP binding site(C) EphA2 ATP binding site. The representative 2F[o] - F[c] electron density around the ATP has been computed at 1.9, 1.6, and 2.3 Å for Aurora-A, FAK, and EphA2, respectively. The density is contoured at 1 s (blue) and 4 s (red). The side chains of the residues that distinguish the structures of the ATP binding sites are shown with the dotted van der Waals surface. Hydrogen bonds between the protein and ATP are shown as dashed lines. The figure was prepared with Xfit [56].
 
  The above figure is reprinted by permission from Cell Press: Structure (2002, 10, 1659-1667) copyright 2002.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21347367 X.Xu, X.Wang, Z.Xiao, Y.Li, and Y.Wang (2011).
Two TPX2-Dependent Switches Control the Activity of Aurora A.
  PLoS One, 6, e16757.  
20632993 C.C.Lee, Y.Jia, N.Li, X.Sun, K.Ng, E.Ambing, M.Y.Gao, S.Hua, C.Chen, S.Kim, P.Y.Michellys, S.A.Lesley, J.L.Harris, and G.Spraggon (2010).
Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
  Biochem J, 430, 425-437.
PDB codes: 3l9p 3lcs 3lct
19494039 F.Hans, D.A.Skoufias, S.Dimitrov, and R.L.Margolis (2009).
Molecular distinctions between Aurora A and B: a single residue change transforms Aurora A into correctly localized and functional Aurora B.
  Mol Biol Cell, 20, 3491-3502.  
19649315 G.Jun, H.Guo, B.E.Klein, R.Klein, J.J.Wang, P.Mitchell, H.Miao, K.E.Lee, T.Joshi, M.Buck, P.Chugha, D.Bardenstein, A.P.Klein, J.E.Bailey-Wilson, X.Gong, T.D.Spector, T.Andrew, C.J.Hammond, R.C.Elston, S.K.Iyengar, and B.Wang (2009).
EPHA2 is associated with age-related cortical cataract in mice and humans.
  PLoS Genet, 5, e1000584.  
19244237 S.Han, A.Mistry, J.S.Chang, D.Cunningham, M.Griffor, P.C.Bonnette, H.Wang, B.A.Chrunyk, G.E.Aspnes, D.P.Walker, A.D.Brosius, and L.Buckbinder (2009).
Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design.
  J Biol Chem, 284, 13193-13201.
PDB codes: 3fzo 3fzp 3fzr 3fzs 3fzt
18574696 A.Poulsen, A.William, A.Lee, S.Blanchard, E.Teo, W.Deng, N.Tu, E.Tan, E.Sun, K.L.Goh, W.C.Ong, C.P.Ng, K.C.Goh, and Z.Bonday (2008).
Structure-based design of Aurora A & B inhibitors.
  J Comput Aided Mol Des, 22, 897-906.  
18662907 B.Zhao, A.Smallwood, J.Yang, K.Koretke, K.Nurse, A.Calamari, R.B.Kirkpatrick, and Z.Lai (2008).
Modulation of kinase-inhibitor interactions by auxiliary protein binding: crystallography studies on Aurora A interactions with VX-680 and with TPX2.
  Protein Sci, 17, 1791-1797.
PDB code: 3e5a
19030106 D.Lietha, and M.J.Eck (2008).
Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation.
  PLoS ONE, 3, e3800.
PDB codes: 2jkk 2jkm 2jko 2jkq
18339619 P.Singh, B.Wang, T.Maeda, K.Palczewski, and J.J.Tesmer (2008).
Structures of rhodopsin kinase in different ligand states reveal key elements involved in G protein-coupled receptor kinase activation.
  J Biol Chem, 283, 14053-14062.
PDB codes: 3c4w 3c4x 3c4y 3c4z 3c50 3c51
18547520 T.L.Davis, J.R.Walker, P.Loppnau, C.Butler-Cole, A.Allali-Hassani, and S.Dhe-Paganon (2008).
Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).
  Structure, 16, 873-884.
PDB codes: 2qo2 2qo7 2qo9 2qob 2qoc 2qod 2qof 2qoi 2qok 2qol 2qon 2qoo 2qoq
18391401 T.M.Bandeiras, R.C.Hillig, P.M.Matias, U.Eberspaecher, J.Fanghänel, M.Thomaz, S.Miranda, K.Crusius, V.Pütter, P.Amstutz, M.Gulotti-Georgieva, H.K.Binz, C.Holz, A.A.Schmitz, C.Lang, P.Donner, U.Egner, M.A.Carrondo, and B.Müller-Tiemann (2008).
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.
  Acta Crystallogr D Biol Crystallogr, 64, 339-353.
PDB code: 2v5q
18451558 Y.Mori, T.Hirokawa, K.Aoki, H.Satomi, S.Takeda, M.Aburada, and K.Miyamoto (2008).
Structure activity relationships of quinoxalin-2-one derivatives as platelet-derived growth factor-beta receptor (PDGFbeta R) inhibitors, derived from molecular modeling.
  Chem Pharm Bull (Tokyo), 56, 682-687.  
17660253 C.N.Cronin, K.B.Lim, and J.Rogers (2007).
Production of selenomethionyl-derivatized proteins in baculovirus-infected insect cells.
  Protein Sci, 16, 2023-2029.  
17574028 D.Lietha, X.Cai, D.F.Ceccarelli, Y.Li, M.D.Schaller, and M.J.Eck (2007).
Structural basis for the autoinhibition of focal adhesion kinase.
  Cell, 129, 1177-1187.
PDB codes: 2j0j 2j0k 2j0l 2j0m
  19662225 J.M.Kneller, T.Ehlen, J.P.Matisic, D.Miller, D.Van Niekerk, W.L.Lam, M.Marra, R.Richards-Kortum, M.Follen, C.Macaulay, and S.J.Jones (2007).
Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.
  Biomark Insights, 2, 447-461.  
17965187 M.Ikuta, M.Kornienko, N.Byrne, J.C.Reid, S.Mizuarai, H.Kotani, and S.K.Munshi (2007).
Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
  Protein Sci, 16, 2626-2635.
PDB codes: 2z7q 2z7r 2z7s
16253994 A.P.Zabell, A.D.Schroff, B.E.Bain, R.L.Van Etten, O.Wiest, and C.V.Stauffacher (2006).
Crystal structure of the human B-form low molecular weight phosphotyrosyl phosphatase at 1.6-A resolution.
  J Biol Chem, 281, 6520-6527.
PDB code: 1xww
17182871 C.Y.Lee, R.O.Andersen, C.Cabernard, L.Manning, K.D.Tran, M.J.Lanskey, A.Bashirullah, and C.Q.Doe (2006).
Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating aPKC/Numb cortical polarity and spindle orientation.
  Genes Dev, 20, 3464-3474.  
16221668 D.F.Ceccarelli, H.K.Song, F.Poy, M.D.Schaller, and M.J.Eck (2006).
Crystal structure of the FERM domain of focal adhesion kinase.
  J Biol Chem, 281, 252-259.
PDB codes: 2aeh 2al6
16889663 J.M.Corsi, E.Rouer, J.A.Girault, and H.Enslen (2006).
Organization and post-transcriptional processing of focal adhesion kinase gene.
  BMC Genomics, 7, 198.  
16557283 K.Strebhardt, and A.Ullrich (2006).
Targeting polo-like kinase 1 for cancer therapy.
  Nat Rev Cancer, 6, 321-330.  
16375648 N.Matthews, C.Visintin, B.Hartzoulakis, A.Jarvis, and D.L.Selwood (2006).
Aurora A and B kinases as targets for cancer: will they be selective for tumors?
  Expert Rev Anticancer Ther, 6, 109-120.  
16785988 S.Ohashi, G.Sakashita, R.Ban, M.Nagasawa, H.Matsuzaki, Y.Murata, H.Taniguchi, H.Shima, K.Furukawa, and T.Urano (2006).
Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies.
  Oncogene, 25, 7691-7702.  
16977320 S.Wiesner, L.E.Wybenga-Groot, N.Warner, H.Lin, T.Pawson, J.D.Forman-Kay, and F.Sicheri (2006).
A change in conformational dynamics underlies the activation of Eph receptor tyrosine kinases.
  EMBO J, 25, 4686-4696.
PDB codes: 2hel 2hen
15837193 C.J.Squire, J.M.Dickson, I.Ivanovic, and E.N.Baker (2005).
Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation.
  Structure, 13, 541-550.
PDB code: 1x8b
15688067 S.K.Mitra, D.A.Hanson, and D.D.Schlaepfer (2005).
Focal adhesion kinase: in command and control of cell motility.
  Nat Rev Mol Cell Biol, 6, 56-68.  
15108811 D.D.Schlaepfer, and S.K.Mitra (2004).
Multiple connections link FAK to cell motility and invasion.
  Curr Opin Genet Dev, 14, 92.  
15062077 G.Snell, C.Cork, R.Nordmeyer, E.Cornell, G.Meigs, D.Yegian, J.Jaklevic, J.Jin, R.C.Stevens, and T.Earnest (2004).
Automated sample mounting and alignment system for biological crystallography at a synchrotron source.
  Structure, 12, 537-545.  
15316025 X.Li, G.Sakashita, H.Matsuzaki, K.Sugimoto, K.Kimura, F.Hanaoka, H.Taniguchi, K.Furukawa, and T.Urano (2004).
Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C.
  J Biol Chem, 279, 47201-47211.  
14625535 M.Carmena, and W.C.Earnshaw (2003).
The cellular geography of aurora kinases.
  Nat Rev Mol Cell Biol, 4, 842-854.  
14580337 R.Bayliss, T.Sardon, I.Vernos, and E.Conti (2003).
Structural basis of Aurora-A activation by TPX2 at the mitotic spindle.
  Mol Cell, 12, 851-862.
PDB codes: 1ol5 1ol6 1ol7
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer